Evaluates efficacy and safety of levacetylleucine in individuals with Ataxia-Telangiectasia, suggesting potential treatment benefits.
To report efficacy and safety results from the pivotal, Phase 3 trial investigating levacetylleucine in people living with Ataxia-Telangiectasia (A-T).
No takes yet. Share an insight, caveat, or question.
Patterson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: